Annarita Armaroli (MD), medical geneticists, she is the clinical person in charge for innovative clinical trials based on antisense approach (Prosensa and GSK) she is now entered in a PhD course, and works on a project aimed at identifing transcription regulatory factors of the dystrophin gene.
